Dispatch Bio is developing a universal immunotherapy by trying to install a synthetic protein — called the “flare” antigen — on every cancer cell in a patient's body.

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Immunotherapy has transformed cancer care, but remains ineffective in 80–90% of patients across many cancer types, emphasizing the need to refine patient selection and improve therapeutic ...

Each My Custom Weight Loss Kit ™ pathway is centered around a different member need, whether it's appetite awareness, energy stabilization, mood support, or post-diet transition.

U.S. officials have approved the first cervical cancer test that allows women to collect their own sample at home ...

The FDA has approved the first cervical cancer testing kit that allows women to collect their own sample at home before shipping it to a laboratory.

Water quality test kits help identify any contaminants in your tap. I put a few picks to the test, allowing me to see what was floating around in my water.

A step towards personalized immunotherapy: MIRO device replicates tumors, environments and interactions by Institute for Bioengineering of Catalonia (IBEC) ...

Procter and Gamble’s “Menopause Stage Indicator” is a urine-based test similar to a pregnancy test stick, and is sold under the Clearblue brand for $30 at mainstream retailers like CVS.

Background: Mutations commonly occur in cancer cells, arising neoantigen as potential targets for personalized immunotherapy of lung adenocarcinoma (LUAD). However, the substantial heterogeneity ...

Bria-OTS is a personalized immunotherapy for metastatic breast cancer, tested alone and with Tevimbra in a phase 1/2 study. The study targets patients unresponsive to at least two systemic therapies, ...

BriaCell (BCTX) Therapeutics reports preclinical data showing strong anti-cancer activity of its next generation, personalized, off-the-shelf, cell-based breast and prostate cancer immunotherapies ...